Morgan Stanley (MS)

Net Receivables

$151.01B

Quarterly · Period ending: · USD

MS logo

MS Net Receivables

Latest reported$151.01B
MS Quarterly Net Receivables ($0.00 → $151.01B)
High-resolution chart · PNG

MS net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Morgan Stanley Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
151,010,000,000
132,599,000,000
114,720,000,000
113,257,000,000
98,310,000,000
92,153,000,000
86,158,000,000
91,380,000,000
88,718,000,000
81,639,000,000
80,105,000,000
76,495,000,000
75,964,000,000
74,095,000,000
78,540,000,000
87,935,000,000
82,759,000,000
94,804,000,000
96,018,000,000
98,353,000,000
100,921,000,000
115,043,000,000
97,737,000,000
72,537,000,000
62,290,000,000
74,424,000,000
55,646,000,000
59,514,000,000
53,381,000,000
52,667,000,000
53,298,000,000
60,839,000,000
61,714,000,000
66,835,000,000
56,187,000,000
54,388,000,000
54,917,000,000
48,344,000,000
46,460,000,000
51,411,000,000
52,827,000,000
44,762,000,000
45,407,000,000
50,070,000,000
57,115,000,000
56,733,000,000
48,961,000,000
54,839,000,000
54,557,000,000
60,506,000,000
57,104,000,000
57,710,000,000
64,473,000,000
62,271,000,000
71,623,000,000
63,578,000,000
56,981,000,000
54,943,000,000
48,669,000,000
54,630,000,000
58,492,000,000
58,930,000,000
54,150,000,000
52,965,000,000
46,483,000,000
42,292,000,000
44,477,000,000
48,678,000,000
44,856,000,000
39,074,000,000
45,587,000,000
14,787,000,000
23,663,000,000
25,442,000,000
100,683,000,000
30,218,000,000
11,991,000,000
25,513,000,000
99,493,000,000
13,403,000,000
16,113,000,000
73,779,000,000
62,146,000,000
12,511,000,000
12,445,000,000
14,701,000,000
18,508,000,000
11,448,000,000
16,593,000,000
17,732,000,000
9,912,000,000
10,263,000,000
12,085,000,000
10,643,000,000
7,142,000,000
11,117,000,000
10,106,000,000
9,013,000,000
11,745,000,000
8,395,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.